REDWOOD CITY, Calif. – Biotricity plans to expand its partnership with the University of Calgary to investigate the use of Heart Rate Variability Monitoring in surgery and illness recovery, and to develop fetal monitoring and sleep apnea devices. “Maternal/fetal monitoring has long included HRVM, and exploring the impact of offering convenience and portability to that patient group, as well as the sleep apnea population, is an exciting opportunity,” said University of Calgary’s Dr. David Liepart in a statement. Biotricity plans to develop a series of medical-grade devices for fetal monitoring and sleep apnea that are applicable in both clinical and home settings. As a result of the expanded partnership, Biotricity founder and CEO Waqaas Al-Siddiq will serve as an advisor on wearables at the University’s College of Medicine and the College of Engineering. “He can bridge the gap between medicine and engineering, and help develop an effective solution for both groups,” said Liepert.
You are here: / / Biotricity, University of Calgary expand monitoring partnership